Related Experiment Videos
A 28-day feeding study with ethyl acetoacetate in rats
W M Cook1, R Purchase, G P Ford
1BIBRA Toxicology International, Carshalton, Surrey, UK.
Summary
Ethyl acetoacetate, a compound evaluated for safety, showed no significant adverse effects in rats during a 28-day dietary study. Minor observations like caecal enlargement and kidney/bladder changes were not considered treatment-related toxic effects.
Area of Science:
- Toxicology
- Rodent Studies
- Dietary Administration
Background:
- Ethyl acetoacetate is a chemical compound with potential applications.
- Assessing the safety of chemical compounds in diet is crucial for risk evaluation.
Purpose of the Study:
- To evaluate the potential toxicity of ethyl acetoacetate when administered orally in the diet of Sprague-Dawley rats.
- To determine dose-related adverse effects and establish a safety profile.
Main Methods:
- Oral administration of ethyl acetoacetate (encapsulated in gum arabic) in diet to male and female rats for 28 days.
- Dose levels: approximately 100, 300, and 1000 mg/kg body weight/day, with a gum arabic control group.
- Comprehensive evaluation including general health, food intake, hematology, serum chemistry, urinalysis, and histopathology.
Main Results:
- No adverse effects on growth, general health, or food intake were observed.
- Minor hematological, serum chemical, and urine variations were not considered treatment-related.
- Caecal enlargement in high-dose males and kidney/bladder changes (proteinaceous casts, nephrocalcinosis) in high-dose females were noted but deemed not treatment-related adverse effects.
Conclusions:
- Ethyl acetoacetate administration in the diet did not result in significant treatment-related adverse effects in rats.
- Observed changes were considered minor, common to the rat strain, or not indicative of toxicity.
- The study suggests a lack of significant toxicity for ethyl acetoacetate under the tested conditions.